Acute and long-term psychiatric side effects of mefloquine: A follow-up on Danish adverse event reports
- 1 January 2015
- journal article
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 13 (1) , 80-88
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Antimalarial chemoprophylaxis and the risk of neuropsychiatric disordersTravel Medicine and Infectious Disease, 2013
- The position of mefloquine as a 21st century malaria chemoprophylaxisMalaria Journal, 2010
- Controversies and Misconceptions in Malaria Chemoprophylaxis for TravelersJAMA, 2007
- The Risk of Severe Depression, Psychosis or Panic Attacks with Prophylactic AntimalarialsDrug Safety, 2004
- Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm studyBMJ, 2003
- Mefloquine for Malaria Chemoprophylaxis 1992–1998: A ReviewJournal of Travel Medicine, 1999
- Clinical Pharmacokinetics of MefloquineClinical Pharmacokinetics, 1990
- Treatment of Falciparum Malaria with Quinine and Tetracycline or Combined Mefloquine/Sulfadoxine/Pyrimethamine on the Thai-Kampuchean BorderThe American Journal of Tropical Medicine and Hygiene, 1986
- Chemosuppressive Field Trials in ThailandThe American Journal of Tropical Medicine and Hygiene, 1980
- Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.BMJ, 1977